|
US5800815A
(en)
|
1903-05-05 |
1998-09-01 |
Cytel Corporation |
Antibodies to P-selectin and their uses
|
|
US4450103A
(en)
|
1982-03-01 |
1984-05-22 |
Cetus Corporation |
Process for recovering human IFN-β from a transformed microorganism
|
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
|
US4737462A
(en)
|
1982-10-19 |
1988-04-12 |
Cetus Corporation |
Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4959314A
(en)
|
1984-11-09 |
1990-09-25 |
Cetus Corporation |
Cysteine-depleted muteins of biologically active proteins
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
ATE120454T1
(de)
|
1988-06-14 |
1995-04-15 |
Cetus Oncology Corp |
Kupplungsmittel und sterisch gehinderte, mit disulfid gebundene konjugate daraus.
|
|
WO1989012631A1
(en)
|
1988-06-24 |
1989-12-28 |
The Dow Chemical Company |
Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates
|
|
US5753627A
(en)
|
1988-12-05 |
1998-05-19 |
Novartis Ag |
Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5705363A
(en)
|
1989-03-02 |
1998-01-06 |
The Women's Research Institute |
Recombinant production of human interferon τ polypeptides and nucleic acids
|
|
ES2070329T3
(es)
|
1989-07-20 |
1995-06-01 |
Sandoz Ltd |
Derivados de polipeptidos.
|
|
US5730978A
(en)
|
1989-09-01 |
1998-03-24 |
Fred Hutchinson Cancer Research Center |
Inhibition of lymphocyte adherence with α4β1-specific antibodies
|
|
US6033665A
(en)
|
1989-09-27 |
2000-03-07 |
Elan Pharmaceuticals, Inc. |
Compositions and methods for modulating leukocyte adhesion to brain endothelial cells
|
|
US5292658A
(en)
|
1989-12-29 |
1994-03-08 |
University Of Georgia Research Foundation, Inc. Boyd Graduate Studies Research Center |
Cloning and expressions of Renilla luciferase
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
IL99552A0
(en)
|
1990-09-28 |
1992-08-18 |
Ixsys Inc |
Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
|
|
CA2103553A1
(en)
|
1991-12-10 |
1993-06-11 |
Garry E. Kiefer |
Bicyclopolyazamacrocyclocarboxylic acid complexes their conjugates, processes for their preparation, and use as radiopharmaceuticals
|
|
DK0626861T4
(da)
|
1992-01-13 |
2004-08-16 |
Biogen Inc |
Behandling af astma.
|
|
JPH07506566A
(ja)
|
1992-02-12 |
1995-07-20 |
バイオゲン インコーポレイテッド |
炎症性胃腸病の処置
|
|
SG52262A1
(en)
|
1993-01-08 |
1998-09-28 |
Tanabe Seiyaku Co |
Peptide inhibitors of cell adhesion
|
|
DK0678122T3
(da)
|
1993-01-12 |
2000-03-06 |
Biogen Inc |
Rekombinante anti-VLA4 antistofmolekyler
|
|
US5914110A
(en)
|
1993-09-07 |
1999-06-22 |
Smithkline Beecham Corporation |
Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
|
|
US5928904A
(en)
|
1993-09-07 |
1999-07-27 |
Smithkline Beecham Corporation |
DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
|
|
WO1995015973A1
(en)
|
1993-12-06 |
1995-06-15 |
Cytel Corporation |
Cs-1 peptidomimetics, compositions and methods of using the same
|
|
US5936065A
(en)
|
1993-12-06 |
1999-08-10 |
Cytel Corporation |
CS-1 peptidomimetics, compositions and methods of using the same
|
|
US5821231A
(en)
|
1993-12-06 |
1998-10-13 |
Cytel Corporation |
CS-1 peptidomimetics, compositions and methods of using same
|
|
US5840299A
(en)
|
1994-01-25 |
1998-11-24 |
Athena Neurosciences, Inc. |
Humanized antibodies against leukocyte adhesion molecule VLA-4
|
|
EP0804237B8
(en)
|
1994-01-25 |
2006-11-08 |
Elan Pharmaceuticals, Inc. |
Humanized antibodies against leukocyte adhesion molecule vla-4
|
|
US8715645B2
(en)
|
1994-05-27 |
2014-05-06 |
The Regents Of The University Of Colorado |
Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same
|
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
WO1996000581A1
(en)
|
1994-06-29 |
1996-01-11 |
Texas Biotechnology Corporation |
Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin
|
|
US5811391A
(en)
|
1994-08-25 |
1998-09-22 |
Cytel Corporation |
Cyclic CS-1 peptidomimetics, compositions and methods of using same
|
|
US5874540A
(en)
|
1994-10-05 |
1999-02-23 |
Immunomedics, Inc. |
CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
|
|
US5674842A
(en)
|
1994-10-26 |
1997-10-07 |
Health Research, Incorporated |
Growth inhibitory peptide
|
|
US5670356A
(en)
|
1994-12-12 |
1997-09-23 |
Promega Corporation |
Modified luciferase
|
|
US6306840B1
(en)
|
1995-01-23 |
2001-10-23 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
WO1996040781A1
(en)
|
1995-06-07 |
1996-12-19 |
Tanabe Seiyaku Co., Ltd. |
CYCLIC PEPTIDE INHIBITORS OF β1 AND β2 INTEGRIN-MEDIATED ADHESION
|
|
CA2245835A1
(en)
*
|
1995-06-14 |
1997-01-03 |
The Regents Of The University Of California |
Novel high affinity human antibodies to tumor antigens
|
|
AU6311996A
(en)
|
1995-07-06 |
1997-02-05 |
Zeneca Limited |
Peptide inhibitors of fibronectine
|
|
US6248713B1
(en)
|
1995-07-11 |
2001-06-19 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
GB9613112D0
(en)
|
1996-06-21 |
1996-08-28 |
Zeneca Ltd |
Chemical compounds
|
|
SG124234A1
(en)
|
1996-07-25 |
2006-08-30 |
Biogen Idec Inc |
Cell adhesion inhibitors
|
|
US6686350B1
(en)
|
1996-07-25 |
2004-02-03 |
Biogen, Inc. |
Cell adhesion inhibitors
|
|
DE19647381A1
(de)
|
1996-11-15 |
1998-05-20 |
Hoechst Ag |
Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
|
|
PL323130A1
(en)
|
1996-11-15 |
1998-05-25 |
Hoechst Ag |
Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
|
|
DE19647380A1
(de)
|
1996-11-15 |
1998-05-20 |
Hoechst Ag |
5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
|
|
WO1998042656A1
(en)
|
1997-03-21 |
1998-10-01 |
Cytel Corporation |
Novel compounds
|
|
CA2291708A1
(en)
|
1997-05-29 |
1998-12-03 |
Merck & Co., Inc. |
Sulfonamides as cell adhesion inhibitors
|
|
EP1017382B1
(en)
|
1997-05-29 |
2006-03-01 |
Merck & Co., Inc. (a New Jersey corp.) |
Biarylalkanoic acids as cell adhesion inhibitors
|
|
EP1001764A4
(en)
|
1997-05-29 |
2005-08-24 |
Merck & Co Inc |
HETEROCYCLIC AMIDE COMPOUNDS AS INHIBITORS OF CELL ADHESION
|
|
JP2002501518A
(ja)
|
1997-05-30 |
2002-01-15 |
セルテック セラピューティックス リミテッド |
抗炎症性チロシン誘導体
|
|
US6191269B1
(en)
|
1997-05-30 |
2001-02-20 |
The Regents Of The University Of California |
Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
|
|
JP2001517246A
(ja)
|
1997-06-23 |
2001-10-02 |
田辺製薬株式会社 |
α▲下４▼β▲下１▼媒介細胞接着の阻止剤
|
|
EP1001971A1
(en)
|
1997-07-31 |
2000-05-24 |
Elan Pharmaceuticals, Inc. |
Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
HUP0003921A3
(en)
|
1997-07-31 |
2001-03-28 |
Wyeth Corp |
Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4, pharmaceutical compositions comprising thereof and their use
|
|
WO1999006433A1
(en)
|
1997-07-31 |
1999-02-11 |
Elan Pharmaceuticals, Inc. |
Compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
EP0994895A1
(en)
|
1997-07-31 |
2000-04-26 |
Elan Pharmaceuticals, Inc. |
Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4
|
|
AR016133A1
(es)
|
1997-07-31 |
2001-06-20 |
Wyeth Corp |
Compuesto de carbamiloxi que inhiben la adhesion de leucocitos mediada por vla-4, compuestos que son prodrogas de dichos compuestos, composicionfarmaceutica, metodo para fijar vla-4 a una muestra biologica, metodo para el tratamiento de una condicion inflamatoria
|
|
JP2001512138A
(ja)
|
1997-07-31 |
2001-08-21 |
エラン・ファーマシューティカルズ・インコーポレーテッド |
Ｖｌａ−４が介在する白血球付着を阻害するベンジル化合物
|
|
BR9812118A
(pt)
|
1997-07-31 |
2000-07-18 |
Elan Pharm Inc |
Compostos do tipo 4-amino-fenilalanina que inibem adesão de leucócito mediada por vla-4
|
|
PL338423A1
(en)
|
1997-07-31 |
2000-11-06 |
Elan Pharm Inc |
Compounds of substituted phenylamine type capable to inhibit adhesion of leucocytes through the mediation of vla-4
|
|
US6455550B1
(en)
|
1997-08-22 |
2002-09-24 |
Hoffmann-La Roche Inc. |
N-alkanoylphenylalanine derivatives
|
|
CN1276785A
(zh)
|
1997-08-22 |
2000-12-13 |
霍夫曼-拉罗奇有限公司 |
N－烷酰基苯丙氨酸衍生物
|
|
BR9811730B1
(pt)
|
1997-08-22 |
2014-04-08 |
Hoffmann La Roche |
Derivados de n-aroilfenilalanina, uso dos mesmos, medicamentos contendo os mesmos.
|
|
US6229011B1
(en)
|
1997-08-22 |
2001-05-08 |
Hoffman-La Roche Inc. |
N-aroylphenylalanine derivative VCAM-1 inhibitors
|
|
DE19741235A1
(de)
|
1997-09-18 |
1999-03-25 |
Hoechst Marion Roussel De Gmbh |
Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
AU1361499A
(en)
|
1997-10-21 |
1999-05-10 |
Merck & Co., Inc. |
Azapeptide acids as cell adhesion inhibitors
|
|
BR9813331A
(pt)
|
1997-10-31 |
2000-08-22 |
Aventis Pharma Ltd |
Composto, uso do mesmo, composição farmacêutica, processo para o tratamento de um paciente humano ou animal não humano que sofra ou esteja sujeito a condições que possam ser melhoradas pela administração de um inibidor da adesão celular mediada pela a4b1, e, resina
|
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
|
AU1415099A
(en)
|
1997-11-18 |
1999-06-07 |
Merck & Co., Inc. |
4-substituted-4-piperidine carboxamide derivatives
|
|
DE19751251A1
(de)
|
1997-11-19 |
1999-05-20 |
Hoechst Marion Roussel De Gmbh |
Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
|
|
AU1411499A
(en)
|
1997-11-20 |
1999-06-15 |
Merck & Co., Inc. |
Para-aminomethylaryl carboxamide derivatives
|
|
AU1463499A
(en)
|
1997-11-21 |
1999-06-15 |
Merck & Co., Inc. |
Substituted pyrrole derivatives as cell adhesion inhibitors
|
|
AU751950B2
(en)
|
1997-11-24 |
2002-09-05 |
Merck & Co., Inc. |
Substituted beta-alanine derivatives as cell adhesion inhibitors
|
|
EP1033983A1
(en)
|
1997-11-24 |
2000-09-13 |
Merck & Co., Inc. |
Cyclic amino acid derivatives as cell adhesion inhibitors
|
|
US6197794B1
(en)
|
1998-01-08 |
2001-03-06 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
|
MY153569A
(en)
|
1998-01-20 |
2015-02-27 |
Mitsubishi Tanabe Pharma Corp |
Inhibitors of ?4 mediated cell adhesion
|
|
HUP0100336A3
(en)
|
1998-01-23 |
2002-11-28 |
Novartis Ag |
Vla-4 antagonists, pharmaceutical compositions comprising them and process for preparing them
|
|
US6329372B1
(en)
|
1998-01-27 |
2001-12-11 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
|
US6171809B1
(en)
|
1998-01-29 |
2001-01-09 |
Packard Instrument Company |
Method and compositions for detecting luciferase biological samples
|
|
EP1056714B1
(en)
|
1998-02-26 |
2004-08-11 |
Celltech Therapeutics Limited |
Phenylalanine derivatives as inhibitors of alpha4 integrins
|
|
US6677436B1
(en)
|
1998-04-03 |
2004-01-13 |
Chugai Seiyaku Kabushiki Kaisha |
Humanized antibody against human tissue factor (TF) and process of production of the humanized antibody
|
|
GB9811159D0
(en)
|
1998-05-22 |
1998-07-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
HUP0102255A3
(en)
|
1998-05-28 |
2001-12-28 |
Biogen Idec Ma Inc Cambridge |
Vla-4 inhibitor omepupa-v, pharmaceutical compositions comprising thereof and their use
|
|
GB9812088D0
(en)
|
1998-06-05 |
1998-08-05 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6685617B1
(en)
|
1998-06-23 |
2004-02-03 |
Pharmacia & Upjohn Company |
Inhibitors of α4β1 mediated cell adhesion
|
|
US6355678B1
(en)
*
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
|
GB9821061D0
(en)
|
1998-09-28 |
1998-11-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
DK1656952T3
(da)
|
1998-10-16 |
2014-01-20 |
Biogen Idec Inc |
Polyalkylenglycolkonjugater af interferon beta-1A og anvendelser deraf
|
|
JP3180906B2
(ja)
|
1998-11-12 |
2001-07-03 |
日本電気株式会社 |
磁気抵抗効果型複合ヘッドの製造方法
|
|
KR100649819B1
(ko)
|
1999-02-18 |
2007-02-28 |
에프. 호프만-라 로슈 아게 |
티오아미드 유도체
|
|
US6265572B1
(en)
|
1999-04-20 |
2001-07-24 |
Hoffmann-La Roche Inc. |
Pyrrolidincarbonylamino cyclic disulfide anti-inflammatory agents
|
|
US6756378B2
(en)
|
1999-06-30 |
2004-06-29 |
Pharmacopeia Drug Discovery, Inc. |
VLA-4 inhibitor compounds
|
|
US7067313B1
(en)
|
1999-07-14 |
2006-06-27 |
D. Collen Research Foundation |
Ligands for use in therapeutic compositions for the treatment of hemostasis disorders
|
|
US6365619B1
(en)
|
1999-07-22 |
2002-04-02 |
Novartis Ag |
Treatment of arteriosclerosis
|
|
GEP20053477B
(en)
|
1999-08-13 |
2005-03-25 |
Biogen Inc |
Cell Adhesion Inhibitors and Pharmaceutical Compositions Containing Them
|
|
US6531122B1
(en)
|
1999-08-27 |
2003-03-11 |
Maxygen Aps |
Interferon-β variants and conjugates
|
|
NZ517740A
(en)
|
1999-09-02 |
2003-09-26 |
Leadd B |
Apoptin-associating protein and its use in the detection the presence of cancer cells
|
|
EP1094110A1
(en)
|
1999-10-21 |
2001-04-25 |
Leadd B.V. |
Apoptosis inducing proteinaceous substance
|
|
EP1233013B1
(en)
|
1999-11-18 |
2007-02-28 |
Ajinomoto Co., Inc. |
Novel phenylalanine derivatives
|
|
US6388084B1
(en)
|
1999-12-06 |
2002-05-14 |
Hoffmann-La Roche Inc. |
4-pyridinyl-n-acyl-l-phenylalanines
|
|
US6380387B1
(en)
|
1999-12-06 |
2002-04-30 |
Hoffmann-La Roche Inc. |
4-Pyrimidinyl-n-acyl-l phenylalanines
|
|
RU2270193C2
(ru)
|
1999-12-06 |
2006-02-20 |
Ф.Хоффманн-Ля Рош Аг |
4-пиридинил-n-ацил-l-фенилаланины
|
|
DE19962936A1
(de)
|
1999-12-24 |
2001-06-28 |
Bayer Ag |
Neue beta-Aminosäureverbindungen als Integrinantagonisten
|
|
EP1244656A1
(en)
|
1999-12-28 |
2002-10-02 |
Pfizer Products Inc. |
Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
|
|
AU2224901A
(en)
|
1999-12-28 |
2001-07-09 |
Ajinomoto Co., Inc. |
Novel phenylalanine derivatives
|
|
US7446174B2
(en)
|
2001-03-02 |
2008-11-04 |
Xencor, Inc. |
Protein based TNF-α variants for the treatment of TNF-α related disorders
|
|
EP1270547A4
(en)
|
2000-03-23 |
2005-07-13 |
Ajinomoto Kk |
NEW PHENYL ALANIDE DERIVATIVES
|
|
ATE321570T1
(de)
|
2000-05-19 |
2006-04-15 |
Blood Res Center |
Verfahren zur behandlung von hämostatischen störungen durch lösliches p-selectin
|
|
GB0027328D0
(en)
*
|
2000-06-23 |
2000-12-27 |
Aventis Pharma Inc |
Bioengineered vehicles for targeted nucleic acid delivery
|
|
US20040247565A1
(en)
|
2000-07-19 |
2004-12-09 |
Chih-Ping Liu |
Method of treatment using interferon-tau
|
|
US7015216B2
(en)
|
2000-07-21 |
2006-03-21 |
Elan Pharmaceuticals, Inc. |
Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors
|
|
WO2002008206A1
(en)
|
2000-07-21 |
2002-01-31 |
Elan Pharmaceuticals, Inc. |
3-amino-2-(4-aminocarbonyloxy)phenyl-propionic acid derivatives as alpha-4- integrin inhibitors
|
|
SK287781B6
(sk)
|
2000-08-18 |
2011-09-05 |
Ajinomoto Co., Inc. |
Fenylalanínové deriváty, farmaceutický prípravok s ich obsahom a ich použitie
|
|
AU2001286242A1
(en)
|
2000-09-14 |
2002-03-26 |
Toray Industries, Inc |
Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
|
|
DE60122555T2
(de)
|
2000-09-25 |
2007-07-12 |
Toray Industries, Inc. |
Spiroverbindungen und diese als wirkstoff enthaltende adhäsionsmolekülinhibitoren
|
|
JP4895067B2
(ja)
|
2000-09-29 |
2012-03-14 |
味の素株式会社 |
新規フェニルアラニン誘導体
|
|
US6818216B2
(en)
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
|
SK286991B6
(sk)
|
2001-02-22 |
2009-09-07 |
Celltech R&D Limited |
Fenylalanínenamidové deriváty, farmaceutický prostriedok obsahujúci tento derivát a použitie
|
|
ES2180416B1
(es)
*
|
2001-03-12 |
2004-06-01 |
BIOTOOLS BIOTECHNOLOGICAL & MEDICAL LABORATORIES, S.A. |
Procedimiento para la preparacion de mezclas de reaccion estabilizadas, total o parcialmente desecadas, que comprenden, al menos, una enzima, mezclas de reaccion y kits que las contienen.
|
|
US7101977B2
(en)
|
2001-07-17 |
2006-09-05 |
Research Development Foundation |
Therapeutic agents comprising pro-apoptotic proteins
|
|
WO2003010135A1
(en)
|
2001-07-26 |
2003-02-06 |
Ajinomoto Co., Inc. |
Novel phenylpropionic acid derivatives
|
|
US6900292B2
(en)
*
|
2001-08-17 |
2005-05-31 |
Lee-Hwei K. Sun |
Fc fusion proteins of human erythropoietin with increased biological activities
|
|
EP1454898A4
(en)
|
2001-12-13 |
2006-12-13 |
Ajinomoto Kk |
NEW PHENYL ALANIDE DERIVATIVES
|
|
KR101271635B1
(ko)
*
|
2001-12-21 |
2013-06-12 |
휴먼 게놈 사이언시즈, 인코포레이티드 |
알부민 융합 단백질
|
|
EP2261250B1
(en)
*
|
2001-12-21 |
2015-07-01 |
Human Genome Sciences, Inc. |
GCSF-Albumin fusion proteins
|
|
AU2003207464A1
(en)
|
2002-01-04 |
2003-07-24 |
Xencor |
Dominant negative proteins and methods thereof
|
|
US20060241132A1
(en)
|
2002-03-22 |
2006-10-26 |
Toray Industries, Inc. A Corporation Of Japan |
Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient
|
|
US7332580B2
(en)
*
|
2002-04-05 |
2008-02-19 |
The Regents Of The University Of California |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
US7332585B2
(en)
*
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
|
GB0216571D0
(en)
|
2002-07-17 |
2002-08-28 |
Celltech R&D Ltd |
Chemical compounds
|
|
GB0216568D0
(en)
|
2002-07-17 |
2002-08-28 |
Celltech R&D Ltd |
Chemical compounds
|
|
US7314613B2
(en)
|
2002-11-18 |
2008-01-01 |
Maxygen, Inc. |
Interferon-alpha polypeptides and conjugates
|
|
US7413874B2
(en)
|
2002-12-09 |
2008-08-19 |
University Of Miami |
Nucleic acid encoding fluorescent proteins from aquatic species
|
|
US20040115204A1
(en)
|
2002-12-11 |
2004-06-17 |
Fanger Gary R. |
Antibodies to treat cancer
|
|
WO2004078112A2
(en)
|
2003-03-07 |
2004-09-16 |
Asahi Kasei Pharma Corporation |
Apoptosis inducing gene
|
|
US7446125B2
(en)
|
2003-04-09 |
2008-11-04 |
Universidad Del Pais Vasco |
Derivatives of nitroproline compounds, processes of manufacture and uses in the treatment of integrin mediated disorders
|
|
GB0308511D0
(en)
|
2003-04-14 |
2003-05-21 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
WO2005035719A2
(en)
|
2003-10-03 |
2005-04-21 |
Board Of Control Of Michigan Technological University |
Modified luciferase
|
|
US7638331B2
(en)
|
2004-01-02 |
2009-12-29 |
The Administration of the Tulane Rducation Fund |
Directed apoptosis in COX-2 overexpressing cancer cells through expression targeted gene delivery
|
|
KR100891620B1
(ko)
|
2004-04-13 |
2009-04-02 |
에프. 호프만-라 로슈 아게 |
항-ｐ-셀렉틴 항체
|
|
CN1997382A
(zh)
|
2004-05-05 |
2007-07-11 |
梅里麦克制药股份有限公司 |
调节生物活性的双特异性结合剂
|
|
TW200610754A
(en)
|
2004-06-14 |
2006-04-01 |
Daiichi Seiyaku Co |
Vla-4 inhibitor
|
|
US7196112B2
(en)
|
2004-07-16 |
2007-03-27 |
Biogen Idec Ma Inc. |
Cell adhesion inhibitors
|
|
US8008447B2
(en)
|
2004-07-23 |
2011-08-30 |
Genentech, Inc. |
Crystallization of antibody or fragment thereof
|
|
CA2599606A1
(en)
|
2005-02-23 |
2006-08-31 |
Merrimack Pharmaceuticals, Inc. |
Bispecific binding agents for modulating biological activity
|
|
MX2007014524A
(es)
|
2005-05-18 |
2008-02-07 |
Maxygen Inc |
Polipeptidos desarrollados de interferon-alfa.
|
|
US8334258B2
(en)
|
2005-07-26 |
2012-12-18 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts (Universitätsmedizin) |
Method for induction and enhancement of apoptosis in tumor cells
|
|
RU2412250C2
(ru)
|
2005-11-04 |
2011-02-20 |
Закрытое акционерное общество "ЕВРОГЕН" |
Модифицированные зеленые флуоресцентные белки и способы их использования
|
|
US20070243163A1
(en)
|
2006-02-17 |
2007-10-18 |
Chih-Ping Liu |
Respiratory tract delivery of interferon-tau
|
|
US8334365B2
(en)
*
|
2006-06-07 |
2012-12-18 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
JP2010503396A
(ja)
*
|
2006-09-14 |
2010-02-04 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
アルブミン融合タンパク質
|
|
CA2721093A1
(en)
|
2008-04-11 |
2009-10-15 |
Merrimack Pharmaceuticals, Inc. |
Human serum albumin linkers and conjugates thereof
|